Transdermal buprenorphine in clinical practice – a post‐marketing surveillance study in 13 179 patients

Abstract

Buprenorphine transdermal patches are well tolerated and effective in the treatment of chronic cancer and non-cancer pain, irrespective of the patients' age. There was no clinically relevant development of tolerance.